Home › Funds › Stephenson & Company, Inc. › MIST
Stephenson & Company, Inc. position in MIST
MILESTONE PHARMACEUTICALS IN · Health Care
Stephenson & Company, Inc. reported holding 20,000 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$27K, representing 0.01% of its reported portfolio and ranking #50 among its reported holdings. Stephenson & Company, Inc. has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Stephenson & Company, Inc.'s MIST position evolved
Stephenson & Company, Inc. first disclosed a stake in MIST in Q3 2025 at 20,000 shares (US$40K). The position peaked in Q4 2025 at 20,000 shares, worth US$40K. Across 4 filings, Stephenson & Company, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 20,000 shares valued at US$27K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 20.00K | $40.00K | New |
| Q4 2025 | 20.00K | $40.40K | Hold |
| Q1 2026 | 20.00K | $23.80K | Hold |
| Q2 2026 | 20.00K | $26.80K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIST and 13F data
MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 31 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$10.0M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$4.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIST
- Propel Bio Management, LLC 7.43M sh · $9.96M · Q2 2026
- Pavaki Capital Management LLC 9.34M sh · $8.08M · Q3 2026
- Simplify Asset Management Inc. 3.35M sh · $4.49M · Q2 2026
- Kalehua Capital Management LLC 1.27M sh · $1.70M · Q2 2026
- Lion Point Capital, LP 820.00K sh · $1.10M · Q2 2026
More on Stephenson & Company, Inc.
FAQ
How long has Stephenson & Company, Inc. held MIST?
Stephenson & Company, Inc. has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Stephenson & Company, Inc.'s current position in MIST?
As of Q2 2026, Stephenson & Company, Inc. holds 20.00K shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $26.80K, representing 0.01% of its reported portfolio and ranking #50.
Has Stephenson & Company, Inc. been buying or selling MIST?
In the latest 13F filing (Q2 2026), Stephenson & Company, Inc. held unchanged its position in MIST. The position peaked in Q4 2025 at 20.00K shares.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.